Monday, July 29, 2024
4:30 PM – 5:30 PM UTC | 6:30 PM – 7:30 PM CEST | 12:30 PM – 1:30 PM EDT
Agenda:
- Introduction by Session Chair – Prof Maryam Lustberg
- Overview of oral targeted therapies for metastatic hormone receptor positive breast cancer – Dr Aditya Bardia
- Management of oral targeted therapy toxicities in breast cancer – Prof Maryam Lustberg
- Patient experience – closing the loop – Abigail Johnston (Patient Partner)
- Panel Discussion and Q&A
Learning Objectives:
- Improve the understanding of clinicians regarding prescribing oral targeted therapies for hormone receptor positive metastatic breast cancer.
- Discuss common toxicities for oral targeted therapies and how to manage them.
- Understanding the patient experience and how it impacts quality of life, adherence, and disease outcomes; and taking a shared decision approach.
Sponsored by Menarini Group/Stemline Therapeutics
Speakers:
Prof Maryam Lustberg
Session Chair
Dr Aditya Bardia
Abigail Johnston
(Patient Partner)
